Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system

Biochimica et Biophysica Acta - General Subjects

Volumn 1810, Issue 1, 2011, Pages 93-110

  Aon Bertolino, Maria Laura ^a   Romero, Juan Ignacio ^a   Galeano, Pablo ^a   Holubiec, Mariana ^a   Badorrey, Maria Sol ^a   Saraceno, Gustavo Ezequiel ^a   Hanschmann, Eva Maria ^b   Lillig, Christopher Horst ^b   Capani, Francisco ^a  

^a Instituto de Investigaciones Cardiologicos Dr Alberto C Taquini   (Argentina)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Brain; CNS; Glutaredoxin; Glutathione; Peroxiredoxin; Thioredoxin

Indexed keywords

GLUTAREDOXIN; GLUTAREDOXIN 1; GLUTAREDOXIN 2; GLUTAREDOXIN 3; GLUTAREDOXIN 5; GLUTATHIONE; OXIDOREDUCTASE; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 4; PEROXIREDOXIN 5; PEROXIREDOXIN 6; THIOREDOXIN; THIOREDOXIN 1; THIOREDOXIN 2; THIOREDOXIN INTERACTING PROTEIN; THIOREDOXIN REDUCTASE 1; THIOREDOXIN REDUCTASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MALE; MOLECULAR INTERACTION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; REPERFUSION INJURY; RETINA; SIGNAL TRANSDUCTION; SPINAL CORD; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ANIMALS; ATLASES AS TOPIC; CENTRAL NERVOUS SYSTEM; GLUTAREDOXINS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; MALE; OXIDATION-REDUCTION; RATS; THIOREDOXINS;

ANIMALIA; MURINAE; RATTUS;

EID: 78649636455     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.06.011     Document Type: Article

References (69)

1. Holmgren A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 1989, 264:13963-13966.
2. Wells W.W., Yang Y., Deits T.L., Gan Z.R. Thioltransferases. Adv. Enzymol. Relat. Areas Mol. Biol. 1993, 66:149-201.
3. Lillig C.H., Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid. Redox Signal. 2007, 9:25-47.
4. Martin J.L. S Thioredoxin-a fold for all reasons. Structure 1995, 3:245-250.
5. Laurent T.C., Moore E.C., Reichard P. Enzymatic synthesis of deoxyribonucleatides. IV isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli. B J Biol Chem 1964, 239:3436-3444.
6. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267:6102-6109.
7. Arner E.S. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim. Biophys. Acta 2009, 1790:495-526.
8. Zhong L., Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J. Biol. Chem. 2000, 275:18121-18128.
9. Bjornstedt M., Hamberg M., Kumar S., Xue J., Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J. Biol. Chem. 1995, 270:11761-11764.
10. May J.M., Mendiratta S., Hill K.E., Burk R.F. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J. Biol. Chem. 1997, 272:22607-22610.
11. Watabe S., Makino Y., Ogawa K., Hiroi T., Yamamoto Y., Takahashi S.Y. Mitochondrial thioredoxin reductase in bovine adrenal cortex its purification, properties, nucleotide/amino acid sequences, and identification of selenocysteine. Eur. J. Biochem. 1999, 264:74-84.
12. Nishiyama A., Matsui M., Iwata S., Hirst K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 1999, 274:21645-21650.
13. Filomeni G., Rotilio G., Ciriolo M.R. Cell signalling and the glutathione redox system. Biochem. Pharmacol. 2002, 64:1057-1064.
14. Meister A., Anderson M.E. Glutathione. Annu Rev Biochem 1983, 52:711-760.
15. Lillig C.H., Berndt C., Holmgren A. Glutaredoxin systems. Biochem Biophys Acta 2008, 1780:1304-1317.
16. Hofmann B., Hecht H.J., Flohe L. Peroxiredoxins. Biol Chem 2002, 383:347-364.
17. Wood Z.A., Schroder E., Robin Harris J., Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003, 28:32-40.
18. Wood Z.A., Schroder E., Robin Harris J., Poole L.B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003, 28:32-40.
19. Rhee S.G., Kang S.W., Chang T.S., Jeong W., Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 2001, 52:35-41.
20. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 2002, 64:1037-1048.
21. Dringen R. Glutathione metabolism and oxidative stress in neurodegeneration. Eur Jm Biochem 2000, 267:4903.
22. Rodriguez V.M., Del Razo L.M., Limon-Pacheco J.H., Giordano M., Sánchez-Pena L.C., Uribe-Querol E., Gutiérrez-Ospina G., Gonsebatt M.E. Glutathione reductase inhibition and methylated arsenic distribution in Cd1 mice brain and liver. Toxicol. Sci. 2005, 84:157-166.
23. Capani F., Loidl C.F., Aguirre F., Piehl L., Facorro G., Hager A., De Paoli T., Farach H., Pecci-Saavedra J. Changes in reactive oxygen species (ROS) production in rat brain during global perinatal asphyxia: an ESR study. Brain Res. 2001, 914:204-207.
24. Capani F., Loidl C.F., Piehl L.L., Facorro G., De Paoli T., Hager A. Long term production of reactive oxygen species during perinatal asphyxia in the rat central nervous system: effects of hypothermia. Int. J. Neurosci. 2003, 113:641-654.
25. Eliasson M.J., Huang Z., Ferrante R.J., Sasamata M., Molliver M.E., Snyder S.H., Moskowitz M.A. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 1999, 19:5910-5918.
26. Singh I.N., Sullivan P.G., Deng Y., Mbye L.H., Hall E.D. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. 2006, 26:1407-1418.
27. Torreilles F., Salman-Tabcheh S., Guerin M., Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev. 1999, 30:153-163.
28. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Brain Res. Rev. 1997, 25:335-358.
29. Dirnagl U., Becker K., Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol. 2009, 8:398-412.
30. Martensson J., Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc. Natl Acad. Sci. USA 1991, 88:4656-4660.
31. Capani F., Saraceno G.E., Boti V., Aon-Bertolino L., Madureira de Oliveria D., Barreto G., Galeano P., Giraldez-Alvarez L.D., Coirini H. Protein ubiquitination in postsynaptic densities after hypoxia in rat neostriatum is blocked by hypothermia. Exp. Neurol. 2009, 219:404-413.
32. Hansson H.A., Rozell B., Stemme S., Engstrom Y., Thelander L., Holmgren A. Different cellular distribution of thioredoxin and subunit M1 of ribonucleotide reductase in rat tissues. Exp. Cell Res. 1986, 163:363-369.
33. Rybnikova E., Damdimopoulos A.E., Gustafsson J.A., Spyrou G., Pelto-Huikko M. Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur. J. Neurosci. 2000, 12:1669-1678.
34. Leifer D., Kowall N.W. Immunohistochemical patterns of selective cellular vulnerability in human cerebral ischemia. J. Neurol. Sci. 1993, 119:217-228.
35. Ordy J.M., Wengenack T.M., Bialobok P., Coleman P.D., Rodier P., Baggs R.B., Dunlap W.P., Kates B. Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Exp. Neurol. 1993, 119:128-139.
36. Rozell B., Hansson H.A., Luthman M., Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur. J. Cell Biol. 1985, 38:79-86.
37. Takagi Y., Tokime T., Nozaki K., Gon Y., Kikuchi H., Yodoi J. Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: immunohistochemical and hybridization studies of thioredoxin. J. Cereb. Blood Flow Metab. 1998, 18:206-214.
38. Takagi Y., Horikawa F., Nozaki K., Sugino T., Hashimoto N., Yodoi J. Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci. Lett. 1998, 251:25-28.
39. Hattori I., Takagi Y., Nozaki K., Kondo N., Bai J., Nakamura H., Hashimoto N., Yodoi J. Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Rep. 2002, 7:256-259.
40. Zhou F., Gomi M., Fujimoto M., Hayase M., Marumo T., Masutani H., Yodoi J., Hashimoto N., Nozaki K., Takagi Y.Y. Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia. Brain Res. 2009, 26:62-70.
41. Moretto N., Bolchi A., Rivetti C., Imbimbo B.P., Villetti G., Pietrini V., Polonelli L., Del Signore S., Smith K.M., Ferrante R.J., Ottonello S. Conformation-sensitive antibodies against Alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J. Biol. Chem. 2007, 282:11436-11445.
42. Hattori I., Takagi Y., Nakamura H., Nozaki K., Bai J., Kondo N., Sugino T., Nishimura M., Hashimoto N., Yodoi J. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid. Redox Signal. 2004, 6:81-87.
43. Tanaka T., Hosoi F., Yamaguchi-Iwai Y., Nakamura H., Masutani H., Ueda S., Nishiyama A., Takeda S., Wada H., Spyrou G., Yodoi J. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 2002, 21:1695-1703.
44. Damdimopoulos A.E., Miranda-Vizuete A., Pelto-Huikko M., Gustafsson J.A., Spyrou G. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 2002, 277:33249-33257.
45. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15:2922-2933.
46. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., Yodoi J. Redox control of cell death. Antioxid. Redox Signal. 2002, 4:405-414.
47. Schweizer U., Bräuer A.U., Köhrle J., Nitsch R., Savaskan N.E. Selenium and brain function: a poorly recognized liaison. Brain Res. Brain Res. Rev. 2004, 45:167-178.
48. Kenchappa R.S., Diwakar L., Boyd M.R., Ravindranath V. Thioltransferase (glutaredoxin) mediates recovery of motor neurons from excitotoxic mitochondrial injury. J. Neurosci. 2002, 22:8402-8410.
49. Balijepalli S., Tirumalai P.S., Swamy K.V., Boyd M.R., Mieyal J.J., Ravindranath V. Rat brain thioltransferase: regional distribution, immunological characterization, and localization by fluorescent in situ hybridization. J. Neurochem. 1999, 72:1170-1178.
50. Takagi Y., Mitsui A., Nishiyama A., Nozaki K., Sono H., Gon Y., Hashimoto N., Yodoi J. Localization of glutaredoxin (thioltransferase) in the rat brain and possible functional implications during focal ischemia. Proc. Natl Acad. Sci. USA 1999, 96:4131-4136.
51. Akterin S., Coburn R.F., Miranda-Vizuete A., Jimenez A., Bogdanovic N., Winblad B., Cedazo-Minguez A. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ. 2006, 13:1454-1465.
52. Landino L.M., Robinson S.H., Skreslet T.E., Cabral D.M. Redox modulation of tau and microtubule-associated protein-2 by the glutathione/glutaredoxin reductase system. Biochem. Biophys. Res. Commun. 2004, 323:112-117.
53. Saeed U., Durgadoss L., Valli R.K., Joshi D.C., Joshi P.G., Ravindranath V. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases. PLoS ONE 2008, 3:e2459.
54. Villapol S., Gelot A., Renolleau S., Charriaut-Marlangue C. Astrocyte responses after neonatal ischemia: the yin and the yang. Neuroscientist 2008, 14:339-344.
55. Kahlert S., Reiser G. Glial perspectives of metabolic states during cerebral hypoxia-calcium regulation and metabolic energy. Cell Calcium 2004, 36:295-302.
56. Karunakaran S., Saeed U., Ramakrishnan S., Koumar R.C., Ravindranath V. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain. Brain Res. 2007, 1185:8-17.
57. Lönn M., Hudemann C., Berndt C., Cherkasov V., Capani F., Holmgren A., Lillig C.H. Expression pattern of human glutaredoxin 2 isoforms: identification and characterization of two testis/cancer cell-specific isoforms. Antioxid. Redox Signal. 2008, 10:537-547.
58. Hudemann C., Lönn M., Godoy J.R., Zahedi Avval F., Capani F., Holmgren A., Lillig C.H. Identification, expression pattern, and characterization of mouse glutaredoxin 2 isoforms. Antioxid. Redox Signal. 2009, 11:1-14.
59. Lillig C.H., Lonn M.E., Enoksson M., Fernandes A.P., Holmgren A. Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc. Natl Acad. Sci. USA 2004, 101:13227-13232.
60. Sandhu SK Kaur G. Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes. Biogerontology 2002, 3(3):161-173. PubMed PMID:12075135.
61. Kenchappa R.S., Ravindranath V. Gamma-glutamyl cysteine synthetase is up-regulated during recovery of brain mitochondrial complex I following neurotoxic insult in mice. Neurosci. Lett. 2003, 350(1):51-55. Oct 16, PubMed PMID:12962915.
62. Kang Y., Viswanath V., Jha N., Qiao X., Mo J.Q., Andersen J.K. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patterns correlate with regional-specific enzyme activities and glutathione levels. J. Neurosci. Res. 1999, 58:436-441.
63. Wang X., Phelan S.A., Forsman-Semb K., Taylor E.F., Petros C., Brown A., Lerner C.P., Paigen B. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J. Biol. Chem. 2003, 278:25179-25190.
64. Mizusawa H., Ishii T., Bannai S. Peroxiredoxin I (macrophage 23kDa stress protein) is highly and widely expressed in the rat nervous system. Neurosci. Lett. 2000, 283:57-60.
65. Sarafian T.A., Verity M.A., Vinters H.V., Shih C.C., Shi L., Ji X.D., Dong L., Shau H. Differential expression of peroxiredoxin subtypes in human brain cell types. J. Neurosci. Res. 1999, 56:206-212.
66. Nakaso K., Kitayama M., Mizuta E., Fukuda H., Ishii T., Nakashima K., Yamada K. Co-induction of heme oxygenase-1 and peroxiredoxin I in astrocytes and microglia around hemorrhagic region in the rat brain. Neurosci. Lett. 2000, 293:49-52.
67. Chen W., Ji J., Xu X., He S., Ru B. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int. J. Dev. Neurosci. 2003, 21:209-216.
68. Kim S.H., Fountoulakis M., Cairns N., Lubec G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J. Neural Transm. Suppl. 2001, 223-235.
69. Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M., Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 2003, 967:152-160.